The Cancer Diagnostic Market is expected to increase in global worth from USD 184.37 billion in 2024 to USD 345.57 billion in 2033, with a Compound Annual Growth Rate of 7.23% between 2025 and 2033. Increasing cancer rates, advancements in diagnostic tools, and greater awareness of early detection drive the growth in cancer diagnostics. The demand for personalized medicine and improved imaging services further expands market opportunities, making cancer diagnostics a crucial segment in healthcare for early detection and better patient outcomes. Read More: https://www.renub.com/retinal-surgery-device-market-global-forecast-p.php The report Cancer Diagnostics Market & Forecast covers by Application (Breast, Colorectal, Cervical, Lung, Prostate, Skin, Blood, Kidney, Liver, Pancreatic, Ovarian), Test Type (Tumor Biomarkers, Imaging, Biopsy, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization), End-User (Diagnostic Centers, Hospitals and Clinics, Research Institutes, Others), Country and Company 2025-2033. #Cancer_Diagnostics_Market